208000009415 Spinocerebellar Ataxias Diseases 0.000 claims abstract description 7.241000580858 Simian-Human immunodeficiency virus Species 0.000 claims abstract description 7.208000003055 Prion Disease Diseases 0.000 claims abstract description 7.208000001282 Primary Progressive Aphasia Diseases 0.000 claims abstract description 7.206010028289 Muscle atrophy Diseases 0.000 claims abstract description 7.206010028003 Motor neurone disease Diseases 0.000 claims abstract description 7.208000005264 Motor Neuron Disease Diseases 0.000 claims abstract description 7.201000011240 frontotemporal dementia Diseases 0.000 claims abstract description 9.201000004810 vascular dementia Diseases 0.000 claims abstract description 10.208000003715 Parkinsonian Disorders Diseases 0.000 claims abstract description 10.201000002832 Lewy body dementia Diseases 0.000 claims abstract description 10.
208000009829 Lewy Body Disease Diseases 0.000 claims abstract description 10. 201000001971 Huntington's disease Diseases 0.000 claims abstract description 11. 
206010057668 Cognitive disease Diseases 0.000 claims abstract description 14. 206010034010 Parkinsonism Diseases 0.000 claims abstract description 16. 206010002026 Amyotrophic lateral sclerosis Diseases 0.000 claims abstract description 16. 201000002212 progressive supranuclear palsy Diseases 0.000 claims abstract description 21. 206010012289 Dementia Diseases 0.000 claims abstract description 21. 206010001897 Alzheimer's disease Diseases 0.000 claims abstract description 33. 241000605947 Roseburia Species 0.000 claims abstract description 39. 206010061536 Parkinson's disease Diseases 0.000 claims abstract description 56. 230000001580 bacterial Effects 0.000 title claims abstract description 186. 239000000203 mixture Substances 0.000 title claims abstract description 412. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to GBGB1709466.5A priority Critical patent/GB201709466D0/en Priority to GBGB1709533.2A priority patent/GB201709533D0/en Application filed by 4D Pharma Research Ltd filed Critical 4D Pharma Research Ltd Priority to PCT/EP2018/065808 priority patent/WO2018229188A1/en Application granted granted Critical Publication of ES2841902T3 publication Critical patent/ES2841902T3/en Status Active legal-status Critical Current Anticipated expiration legal-status Critical Links Original Assignee 4D Pharma Research Ltd Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Inventor Imke Elisabeth MULDER Anna Ettorre Suaad Ahmed Parthena Fotiadou Samantha Yuille Helene Savignac Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active Application number ES18731444T Other languages Spanish ( es) #Emulsion de scott para que sirve pdf
Compositions comprising bacterial strainsĭownload PDF Info Publication number ES2841902T3 ES2841902T3 ES18731444T ES18731444T ES2841902T3 ES 2841902 T3 ES2841902 T3 ES 2841902T3 ES 18731444 T ES18731444 T ES 18731444T ES 18731444 T ES18731444 T ES 18731444T ES 2841902 T3 ES2841902 T3 ES 2841902T3 Authority ES Spain Prior art keywords disease compositions composition bacterial strain roseburia Prior art date Legal status (The legal status is an assumption and is not a legal conclusion.
0 kommentar(er)
